Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg QD and Naproxen 500 mg BID in Treating the Signs and Symptoms of Osteoarthritis of the Knee

NCT00652808 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00652808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00652808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Double Dummy, Randomized Comparison Study to Evaluate the Efficacy and Safety of Valdecoxib 10 mg QD and Naproxen 500 mg BID in Treating the Signs and Symptoms of Osteoarthritis of the Knee
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2004
Completion date
September 30, 2004
Enrollment
265 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

knee, osteoarthritis